Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
4.100
+0.230 (5.94%)
Nov 21, 2025, 3:19 PM EST - Market open
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $13.91 million as of November 21, 2025. Its market cap has decreased by -27.55% in one year.
Market Cap
13.91M
Enterprise Value
15.36M
1-Year Change
-27.55%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since January 17, 2014, Ekso Bionics Holdings's market cap has decreased from $15.60M to $13.91M, a decrease of -10.83%. That is a compound annual growth rate of -0.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 10.60M | -20.90% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | 585.26% |
| Jan 17, 2014 | 15.60M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |